Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer
- 1 November 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 157 (5) , 1563-1573
- https://doi.org/10.1016/s0002-9440(10)64793-1
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivoCurrent Biology, 1998
- Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.Journal of Clinical Investigation, 1996
- Binding of Cell-Surface Expressed CD44 to Hyaluronate Is Dependent on Splicing and Cell TypeBiochemical and Biophysical Research Communications, 1995
- Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.The Journal of cell biology, 1995
- Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.The Journal of cell biology, 1993
- Expression of hepatocyte growth factor gene in endothelial and kupffer cells of damaged rat livers, as revealed by insitu hydridizationBiochemical and Biophysical Research Communications, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrinThe Journal of cell biology, 1988
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987